Using computational approaches to repurpose a safe clinical compound

Research unit

INNOSUISSE

Project number

45672.1 IP-LS

Project title

Using computational approaches to repurpose a safe clinical compound

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Category	Text
Short description (German)	Using computational approaches to repurpose a safe clinical compound
Short description (English)	Using computational approaches to repurpose a safe clinical compound
Abstract (German)	This project will leverage molecular modelling and artificial intelligence approaches developed by the Swiss Institute of Bioinformatics to identify new therapeutic indications for a promising bioactive, safe and well-tolerated compound, owned by the Addex Therapeutics company.